Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Concert Pharmaceuticals

Biotech & Life Sciences · Lexington, United States · Founded 2006 · IPO 2014 Thoroughbred

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$267M
Market cap · 2026
Revenue
$32M
Latest reported FY

Investors

2 investors on Concert Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Series B+ 1 investor entered at this stage

See Concert Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.